Login to Your Account

Euroscience Open Forum 2012

IMI on the Move to Improve Drug Development in Europe

By Nuala Moran
Staff Writer

Wednesday, July 18, 2012
DUBLIN, Ireland – It has not been long since the first research programs got under way, but there is evidence already that projects undertaken by the €2 billion (US$2.4 billion) Innovative Medicines Initiative (IMI) are having an impact on the environment for drug development in Europe.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription